In conclusion, our study observed that the downregulation of AGR2, p21, and cyclin D1 and the presence of the suggestive p53 mutation were associated with tumor aggressiveness characteristics such as progression, invasion, death, relapse, and worse DFS. Here, CDKN1A is linked to neoplasm.